Centre for Innovative Biomedicine and Biotechnology
CiBB is a Research Unit of excellence at the University of Coimbra and an international reference in the domains of Biomedicine and Biotechnology
CiBB is a R&D Unit and an Associate Laboratory which integrates
Q1 Publications | Data from 2018-2023
>2500
Publications
Researchers from
Faculties of Medicine, Pharmacy, Sciences and Economics
Coimbra University Hospital
Key collaborators from biotech and pharma industry
More than 700 members
> 320 Integrated PhD-holders
> 220 PhD students
> 180 Collaborators
Research-oriented Advanced Training
10 PhD Programs
8 MSc Programs
European Training Networks (H2020 MSCA‑ETN)
Highly Internationalized Research
50% of publications as
International Collaborations
Projects
International Projects funded by the European Union, International Foundations and the Private Sector
Clinicians at CiBB
> 50 clinicians
Technology Transfer
30 active IP families
15 Granted IP
9 active Spin-offs
> 20 academia-industry contracts
Selected prizes (2025)
“La Caixa” Health Research
Maria de Sousa Award by Bial
Proof of Concept Acelera @ UC
Several CiBB Researchers have leadership roles in major international scientific societies (eg: European Society for Clinical Investigation - ESCI and European Society for Neurochemistry - ESN) and national scientific societies (eg: Biochemistry, Neuroscience, Pharmacology, Stem Cells & Cell Therapies, Cardiology)
Science Communication
> 690 News | > 12.5M Audiences
> 37 k social networks followers
Public Engagement Activities | > 12.5 k people reached | > 400 researchers involved | > 25 non-academic collaborations
Data from 2025
We use cookies to improve your visit to our website.
